<DOC>
	<DOCNO>NCT00830960</DOCNO>
	<brief_summary>The study compare safety efficacy prasugrel , administer different dos clopidogrel treatment Asian participant acute coronary syndrome ( ACS ) undergo percutaneous coronary intervention .</brief_summary>
	<brief_title>A Comparison Antiplatelet Therapies Asian Subjects With Acute Coronary Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Prasugrel Hydrochloride</mesh_term>
	<criteria>A person diagnose acute coronary syndrome ( ACS ) undergo percutaneous coronary intervention ( PCI ) A person East Southeast Asian descent A person legal age 18 ( age 21 Singapore ) mentally competent provide sign write informed consent enter study If woman childbearing potential , must test negative pregnancy agree use reliable method birth control A person severe cardiovascular condition cardiogenic shock time randomization , ventricular arrhythmia congestive heart failure A person increase risk bleeding ( e.g . active internal bleeding , history bleed disorder , recent fibrinolytic therapy randomization study ) A person prior history one following : ischemic hemorrhagic stroke ; intracranial neoplasm , arteriovenous malformation , aneurysm ; prior history transient ischemic attack ( TIA ) A person need take antiplatelet therapy Aspirin duration study A person receive daily treatment nonsteroidal antiinflammatory drug ( NSAIDs ) cyclooxygenase2 ( COX2 ) inhibitor discontinue A person severe liver disease , cirrhosis A person condition alcoholism , mental illness , drug dependence</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2011</verification_date>
</DOC>